[HTML][HTML] Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

A McGuigan, P Kelly, RC Turkington… - World journal of …, 2018 - ncbi.nlm.nih.gov
This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

HMGB1 in health and disease

R Kang, R Chen, Q Zhang, W Hou, S Wu, L Cao… - Molecular aspects of …, 2014 - Elsevier
Complex genetic and physiological variations as well as environmental factors that drive
emergence of chromosomal instability, development of unscheduled cell death, skewed …

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

Y Pylayeva-Gupta, KE Lee, CH Hajdu, G Miller… - Cancer cell, 2012 - cell.com
Stromal responses elicited by early stage neoplastic lesions can promote tumor growth.
However, the molecular mechanisms that underlie the early recruitment of stromal cells to …

Plasma circulating tumor DNA in pancreatic cancer patients is a prognostic marker

D Pietrasz, N Pécuchet, F Garlan, A Didelot… - Clinical Cancer …, 2017 - AACR
Purpose: Despite recent therapeutic advances, prognosis of patients with pancreatic
adenocarcinoma remains poor. Analyses from tumor tissues present limitations; …

Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers

BD White, AJ Chien, DW Dawson - Gastroenterology, 2012 - Elsevier
Aberrant Wnt/β-catenin signaling is widely implicated in numerous malignancies, including
cancers of the gastrointestinal tract. Dysregulation of signaling is traditionally attributed to …

[HTML][HTML] EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma

C Navas, I Hernández-Porras, AJ Schuhmacher… - Cancer cell, 2012 - cell.com
Clinical evidence indicates that mutation/activation of EGF receptors (EGFRs) is mutually
exclusive with the presence of K-RAS oncogenes in lung and colon tumors. We have …

[HTML][HTML] Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer

J Swierczynski, A Hebanowska… - World journal of …, 2014 - ncbi.nlm.nih.gov
There is growing evidence that metabolic alterations play an important role in cancer
development and progression. The metabolism of cancer cells is reprogrammed in order to …

Surgical and molecular pathology of pancreatic neoplasms

WM Hackeng, RH Hruban, GJA Offerhaus… - Diagnostic …, 2016 - Springer
Background Histologic characteristics have proven to be very useful for classifying different
types of tumors of the pancreas. As a result, the major tumor types in the pancreas have long …

MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression

AE Frampton, L Castellano, T Colombo, E Giovannetti… - Gastroenterology, 2014 - Elsevier
Background & Aims There has not been a broad analysis of the combined effects of altered
activities of microRNAs (miRNAs) in pancreatic ductal adenocarcinoma (PDAC) cells, and it …

An aggrephagy-related LncRNA signature for the prognosis of pancreatic adenocarcinoma

X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - mdpi.com
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …